Microinjection technique for pharmacological evaluation of microvascular permeability in human skin.

Abstract:

:A new technique which combines skin microinjection of minute amounts of drugs (0.5 microliter) and measurement of capillary permeability by intravital fluorescence videomicroscopy and densitometry is introduced. Glass micropipettes with a tip diameter of 7-9 microns are inserted by a micromanipulator into the stratum papillare containing the capillary loops and used for microinjection by microsyringe and special dispenser. Transcapillary diffusion of sodium fluorescein applied by intravenous bolus injection is visualised by fluorescence videomicroscopy and stored on videotape. Perivascular fluorescent light intensity (FLI) is measured in arbitrary units (AU) by videodensitometry around the site of microinjection during playback of the videotapes. The method was tested by microinjection of 0.5 microliter histamine (1% solution) at the distal tibial plateau. Mean FLI values representing microvascular permeability were 2186 AU 10 min after microinjection of histamine, 420 AU after physiologic saline and 1228 AU after histamine combined with oral intake of 20 mg cetirizine. Cetirizine significantly reduced (P < 0.01) the increased permeability induced by histamine. However, the mean values after injection of the H1-blocker were still significantly enhanced (P < 0.01) when compared to the mean values observed after injection of physiologic saline solution, which provoked only minor microtrauma. The technique offers new scope for pharmacological testing in man.

journal_name

Eur J Clin Pharmacol

authors

Herrig I,Hoffmann U,Fischer M,Franzeck UK,Bollinger A

doi

10.1007/BF00203779

subject

Has Abstract

pub_date

1996-01-01 00:00:00

pages

365-9

issue

5

eissn

0031-6970

issn

1432-1041

journal_volume

49

pub_type

临床试验,杂志文章
  • Frequency of S-mephenytoin hydroxylation deficiency in 373 Spanish subjects compared to other Caucasian populations.

    abstract::We have investigated the prevalence of poor metabolisers (PM) of S-mephenytoin in 373 unrelated, healthy Spanish Caucasian subjects, based on the enantiomeric S/R mephenytoin ratio in urine collected 0-8 h and 24-32 h after intake of the racemic drug. Five of the subjects were PM (1.34%, 95% confidence interval 0.18-2...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF02440867

    authors: Reviriego J,Bertilsson L,Carrillo JA,Llerena A,Valdivielso MJ,Benítez J

    更新日期:1993-01-01 00:00:00

  • Relationship between renal function and disposition of oral cefixime.

    abstract::The pharmacokinetics of cefixime following a single oral dose of 200 mg have been investigated in 6 normal subjects and in 22 patients with various degrees of renal insufficiency. Serum and urine samples were collected between 0 and 72 h and were subjected to two methods of analysis: bioassay and HPLC. There was a lin...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00314988

    authors: Dhib M,Moulin B,Leroy A,Hameau B,Godin M,Johannides R,Fillastre JP

    更新日期:1991-01-01 00:00:00

  • Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review.

    abstract:BACKGROUND:Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) is a delayed infrequent potentially life-threatening idiosyncratic drug reaction. Aromatic anticonvulsants and allopurinol are the most frequent causative agents. However, various reports of antibiotic-induced DRESS are available. In this...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/s00228-020-03005-9

    authors: Sharifzadeh S,Mohammadpour AH,Tavanaee A,Elyasi S

    更新日期:2020-10-06 00:00:00

  • CYP3A4*1G polymorphism is associated with lipid-lowering efficacy of atorvastatin but not of simvastatin.

    abstract:PURPOSE:Our aim was to observe the impact of CYP3A4*1G genetic polymorphism on lipid-lowering efficacy of statins. METHODS:We studied 217 unrelated hyperlipidemic patients who prospectively received atorvastatin and 199 patients who received simvastatin as a single-agent therapy (20 mg day(-1) p.o.) for 4 weeks. Genot...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-008-0502-x

    authors: Gao Y,Zhang LR,Fu Q

    更新日期:2008-09-01 00:00:00

  • Additional mechanisms of nafamostat mesilate-associated hyperkalaemia.

    abstract:OBJECTIVE:Nafamostat mesilate, a potent protease inhibitor, is widely used for the treatment of pancreatitis, disseminated intravascular coagulation and as an anticoagulant in haemodialysis. However, hyperkalaemia associated with nafamostat mesilate has been reported. It is thought to be due to decreased urinary potass...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s002280050176

    authors: Ookawara S,Tabei K,Sakurai T,Sakairi Y,Furuya H,Asano Y

    更新日期:1996-01-01 00:00:00

  • Metoprolol alpha-hydroxylation is a poor probe for debrizoquine oxidation (CYP2D6) polymorphism in Jordanians.

    abstract::The frequency distribution of the 8-h urinary ratio of log metoprolol/alpha-hydroxymetoprolol was assessed in 65 healthy, unrelated Jordanian volunteers. There was no apparent bimodality in the frequency distribution of this ratio among the subjects studied. The frequency of the poor metabolizer phenotype of metoprolo...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00191160

    authors: al-Hadidi HF,Irshaid YM,Rawashdeh NM

    更新日期:1994-01-01 00:00:00

  • The effect of fluconazole on the pharmacokinetics of rosuvastatin.

    abstract:OBJECTIVE:To examine the effect of fluconazole, a potent inhibitor of CYP2C9 and CYP2C19, on the pharmacokinetics of rosuvastatin in healthy volunteers. Significantly increased plasma concentrations of fluvastatin have been observed following co-administration with fluconazole. METHODS:This was a randomised, double-bl...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s00228-002-0508-8

    authors: Cooper KJ,Martin PD,Dane AL,Warwick MJ,Schneck DW,Cantarini MV

    更新日期:2002-11-01 00:00:00

  • Compliance with quality prescribing indicators in terms of their relationship to financial incentives.

    abstract:OBJECTIVE:To develop quality prescribing indicators for general practitioners (GPs) who are non-monitored and not included in pay-for-performance programs, and to determine compliance with incentivized and non-incentivized indicators. STUDY DESIGN:Descriptive cross sectional study. SETTING:Aljarafe Primary Health Car...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-013-1542-4

    authors: Fernández Urrusuno R,Montero Balosa MC,Pérez Pérez P,Pascual de la Pisa B

    更新日期:2013-10-01 00:00:00

  • Suppression of respiratory burst of polymorphonuclear leukocytes by azelastine hydrochloride (Azeptin).

    abstract::The inhibitory action of azelastine hydrochloride (Azeptin) on the respiratory burst in peripheral polymorphonuclear leukocytes (PMN) and pulmonary alveolar macrophages (PAM) has been studied. Azeptin in vitro suppressed chemiluminescence and superoxide (O2-) generation by human PMN in a dose- and time-dependent manne...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00194963

    authors: Ueta E,Osaki T,Kawasaki N,Nomura Y

    更新日期:1994-01-01 00:00:00

  • Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.

    abstract:PURPOSE:Older people with advanced frailty are among the highest consumers of medications. When life expectancy is limited, some of these medications are likely to be inappropriate. The aim of this study was to compare STOPPFrail, a concise, easy-to-use, deprescribing tool based on explicit criteria, with gold standard...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-018-2598-y

    authors: Curtin D,Dukelow T,James K,O'Donnell D,O'Mahony D,Gallagher P

    更新日期:2019-03-01 00:00:00

  • Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing.

    abstract::Twenty-four healthy volunteers participated in a study on the disposition of ergotamine following oral and rectal administration. Plasma samples were collected surrounding each dose of medication and a new mass spectrometry method was used for quantitation of the samples. A mean peak plasma concentration of 454 pg/ml ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00541538

    authors: Sanders SW,Haering N,Mosberg H,Jaeger H

    更新日期:1986-01-01 00:00:00

  • Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. II. Physiological significance.

    abstract::Guidelines presented previously for the analysis of plasma concentration versus time data for a drug exhibiting concentration-dependent plasma protein binding were successfully applied to the distributional parameters of a new cephalosporin, ceftriaxone. This approach provided several striking observations when the ph...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF01037956

    authors: McNamara PJ,Gibaldi M,Stoeckel K

    更新日期:1983-01-01 00:00:00

  • Effects of adinazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.

    abstract::Effects on psychomotor and cognitive performance of adinazolam (15 or 30 mg), alone and in combination with ethanol (0.8 g/kg), were studied in healthy male volunteers and compared to effects of 10 mg diazepam. Adinazolam 30 mg produced relatively long-lasting impairments on tests of tracking, attention, verbal and no...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00315578

    authors: Linnoila M,Stapleton JM,Lister R,Moss H,Lane E,Granger A,Greenblatt DJ,Eckardt MJ

    更新日期:1990-01-01 00:00:00

  • Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients.

    abstract:PURPOSE:To analyze the clinical features and risk factors of tigecycline-associated hypofibrinogenaemia and study whether cefoperazone/sulbactam combined with tigecycline aggravates coagulopathy or hypofibrinogenaemia. METHODS:A retrospective case-control study of patients with severe infection who were treated with t...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-020-02860-w

    authors: Hu J,Xiao YH,Zheng Y,Lai YX,Fang XL,Fang Q

    更新日期:2020-07-01 00:00:00

  • Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs.

    abstract::Since little is known of the number and types of binding sites on alpha 1-acid glycoprotein (AAG) and because drug-drug protein binding interactions often fail to fit a simple model, a study of the effect of 9 known AAG binding drugs on lidocaine free fraction (LFF) was performed. Serum was obtained from 10 healthy ma...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF01037957

    authors: Goolkasian DL,Slaughter RL,Edwards DJ,Lalka D

    更新日期:1983-01-01 00:00:00

  • Interactions between cardioactive drugs and antidepressants.

    abstract::The most important cardiovascular interactions between cardioactive drugs and monoamino-oxidase inhibitors or tricyclic antidepressants are reviewed. Post-ganglion blocking agents (e.g., guanethidine), clonidine, reserpine, and alpha-methyl-dopa should not be used in patients needing antide-present therapy. For hypert...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/BF00566537

    authors: Cocco G,Agué C

    更新日期:1977-01-01 00:00:00

  • A double blind trial of UK-38,485, an orally active thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome.

    abstract::Ten patients with moderate to severe Raynaud's syndrome were recruited into a four week randomised double blind crossover study to compare the efficacy of UK-38,485 50 mg, a new thromboxane synthetase inhibitor with that of placebo. With the doses used there was no significant difference between the two treatment peri...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Rustin MH,Grimes SM,Kovacs IB,Cooke ED,Bowcock SA,Sowemimo-Coker SO,Turner P,Kirby JD

    更新日期:1984-01-01 00:00:00

  • Quality and impact of problem-oriented drug information: a method to change clinical practice among physicians?

    abstract:OBJECTIVES:Problem-oriented drug information is characterised by health professionals actively seeking drug information through various sources. In this study our objective was to determine the quality and impact of problem-oriented drug information among physicians. METHODS:Evaluation forms accompanying 163 written a...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-001-0386-5

    authors: Schjøtt J,Pomp E,Gedde-Dahl A

    更新日期:2002-02-01 00:00:00

  • Captopril does not interact with the pharmacodynamics and pharmacokinetics of digitoxin in healthy man.

    abstract::The chronic oral administration of 0.07 mg digitoxin o.d. for up to 58 days to 12 healthy volunteers caused a small drop in mean heart rate HR (95% CI: -7.9 to -1.6 beats.min-1), in mean diastolic blood pressure (95% CI: -8.3 to -0.4 mmHg), shortening of the QTc-interval (95% CI: -42 to -19 ms), shortening of the HR-c...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/BF02220626

    authors: de Mey C,Elich D,Schroeter V,Butzer R,Belz GG

    更新日期:1992-01-01 00:00:00

  • The influence of haemodialysis and haemofiltration on the clearance of torasemide in renal failure.

    abstract::The concentration of Torasemide in plasma, dialysate and ultrafiltrate were determined during one haemofiltration and three dialyses. Results show that Torasemide is not significantly eliminated from the blood by these technics. ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00541468

    authors: Loute G,Adam A,Ers P,Heremans C,Willems B

    更新日期:1986-01-01 00:00:00

  • The pharmacokinetics of vancomycin in patients with severe acute pancreatitis.

    abstract:OBJECTIVE:The aim of this study was to evaluate the pharmacokinetics of vancomycin in patients with severe acute pancreatitis (SAP). METHODS:Sixty-seven patients with SAP were included. The FPIA method was used to measure vancomycin serum trough concentrations, and the pharmacokinetic parameters were calculated using ...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-016-2018-0

    authors: He J,Mao EQ,Feng J,Jiang HT,Yang WH,Chen EZ

    更新日期:2016-06-01 00:00:00

  • Differences in the bioavailability of dihydrotachysterol preparations.

    abstract::The bioavailability of four preparations containing dihydrotachysterol (DHT2) was tested in two separate trials with administration of single, oral doses of 1 mg per individual. The relative bioavailability of corresponding preparations (capsules vs capsules and oral solution vs oral solution) was tested in a randomis...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00193484

    authors: Koytchev R,Alken RG,Vagaday M,Kunter U,Kirkov V

    更新日期:1994-01-01 00:00:00

  • Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase.

    abstract::Deuterated methadone (M-d3) and GCMS were used to study the pharmacokinetics of methadone (M) during the induction stage of methadone maintenance treatment (MMT). A pulse dose of M-d3 was given on Days 1 and 25 of two dosage regimens, one with a continuous 30 mg dose (n = 6), and the other with 30 mg for 10 days, foll...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00548404

    authors: Nilsson MI,Anggård E,Holmstrand J,Gunne LM

    更新日期:1982-01-01 00:00:00

  • Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients.

    abstract:OBJECTIVE:The aim of this study was to compare the effects of benazepril and amlodipine in monotherapy versus in combination with plasma t-PA and PAI-1 activity in hypertensive type-2 diabetic patients. METHODS:After an initial 6-week wash-out, single-blind placebo period, 38 patients, 17 men and 21 females, were rand...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s00228-003-0621-3

    authors: Fogari R,Preti P,Lazzari P,Corradi L,Zoppi A,Fogari E,Mugellini A

    更新日期:2003-08-01 00:00:00

  • How many patients and blood levels are necessary for population pharmacokinetic analysis? A study of a one compartment model applied to cyclosporine.

    abstract:OBJECTIVE:This paper describes a method to determine the number of patients and the number of blood levels which are appropriate for a pharmacokinetic population analysis. METHODS:We studied this question by performing 203 runs of population analysis, using the NPEM algorithm with a one compartment model, starting wit...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s002280050199

    authors: Bréant V,Charpiat B,Sab JM,Maire P,Jelliffe RW

    更新日期:1996-01-01 00:00:00

  • Placebo? no thanks, it might be bad for me!

    abstract:OBJECTIVE:To assess the potential damage to patients from the inappropriate use of placebo. METHODS:Pivotal clinical trials of new drugs were evaluated for the treatment of multiple sclerosis following effective treatment with beta interferons and glatiramer acetate. The differences in the relapse rate between the exp...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-012-1383-6

    authors: Garattini S,Bertelé V,Banzi R

    更新日期:2013-03-01 00:00:00

  • Grapefruit juice has no effect on quinine pharmacokinetics.

    abstract:OBJECTIVE:As quinine is mainly metabolised by human liver CYP3A4 and grapefruit juice inhibits CYP3A4, the effect of grapefruit juice on the pharmacokinetics of quinine following a single oral dose of 600 mg quinine sulphate was investigated. METHODS:The study was carried out in ten healthy volunteers using a randomis...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s002280050646

    authors: Ho PC,Chalcroft SC,Coville PF,Wanwimolruk S

    更新日期:1999-07-01 00:00:00

  • Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil.

    abstract:AIM:It has been reported that verapamil and atorvastatin are inhibitors of both P-glycoprotein (P-gp) and microsomal cytochrome P450 (CYP) 3A4, and verapamil is a substrate of both P-gp and CYP3A4. Thus, it could be expected that atorvastatin would alter the absorption and metabolism of verapamil. METHODS:The pharmaco...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s00228-007-0447-5

    authors: Choi DH,Shin WG,Choi JS

    更新日期:2008-05-01 00:00:00

  • Human pharmacokinetics of nitrazepam: effect of age and diseases.

    abstract::Plasma concentrations of nitrazepam were measured by gas-liquid chromatography in: young healthy volunteers, in geriatric and psychiatric patients and in epileptic children. The disposition of nitrazepam was described in terms of a two-compartment open model. After a single oral dose of nitrazepam 5 mg the most promin...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00563100

    authors: Kangas L,Iisalo E,Kanto J,Lehtinen V,Pynnönen S,Ruikka I,Salminen J,Sillanpää M,Syvälahti E

    更新日期:1979-04-17 00:00:00

  • CYP450 polymorphisms and clinical pharmacogenetics of ibuprofen after lower third molar extraction.

    abstract:PURPOSE:This study hypothesized that drugs accumulate in the bloodstream of poor-metabolizing patients and may have more adverse effects and different pain perceptions and aimed to investigate the influence of CYP450 polymorphisms on acute postoperative pain, swelling, and trismus controlled by ibuprofen (600 mg) in 20...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-020-03046-0

    authors: Weckwerth GM,Dionísio TJ,Costa YM,Colombini-Ishiquiriama BL,Oliveira GM,Torres EA,Bonjardim LR,Calvo AM,Moore T,Absher DM,Santos CF

    更新日期:2020-11-17 00:00:00